Masimo (MASI) EBT Margin Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -405.00 |
| Jan 3, 2026 | -405.00 |
| Sep 27, 2025 | -179.00 |
| Jun 28, 2025 | -620.00 |
| Mar 29, 2025 | -845.00 |
| Dec 28, 2024 | -4,767.00 |
| Sep 28, 2024 | -1,523.00 |
| Jun 29, 2024 | -1,523.00 |
| Mar 30, 2024 | -1,364.00 |
| Dec 30, 2023 | -4,636.00 |
| Sep 30, 2023 | -2,066.00 |
| Jul 1, 2023 | -1,961.00 |
| Apr 1, 2023 | -2,144.00 |
| Dec 31, 2022 | -1,383.00 |
| Oct 1, 2022 | -1,295.00 |
| Jul 2, 2022 | -1,818.00 |
| Apr 2, 2022 | -754.00 |
| Jan 1, 2022 | -15,254.00 |
| Oct 2, 2021 | 48.00 |
| Jul 3, 2021 | 0.00 |
| Apr 3, 2021 | -39.00 |
| Jan 2, 2021 | -522.00 |
| Sep 26, 2020 | 420.00 |
| Jun 27, 2020 | 399.00 |
| Mar 28, 2020 | 902.00 |
| Dec 28, 2019 | 583.00 |
| Sep 28, 2019 | 868.00 |
| Jun 29, 2019 | 1,089.00 |
| Mar 30, 2019 | 412.00 |
| Dec 29, 2018 | 1,654.00 |
| Sep 29, 2018 | 832.00 |
| Jun 30, 2018 | 836.00 |
| Mar 31, 2018 | 1,077.00 |
| Dec 30, 2017 | 595.00 |
| Sep 30, 2017 | 658.00 |
| Jul 1, 2017 | 479.00 |
| Apr 1, 2017 | 873.00 |
| Dec 31, 2016 | 15,872.00 |
| Oct 1, 2016 | 354.00 |
| Jul 2, 2016 | 69.00 |
| Apr 2, 2016 | -53.00 |
| Jan 2, 2016 | -1,666.00 |
| Oct 3, 2015 | -608.00 |
| Jul 4, 2015 | -415.00 |
| Apr 4, 2015 | -2,313.00 |
| Sep 27, 2014 | -911.00 |
| Jun 28, 2014 | -1,102.00 |